UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
"The MHRA's authorization of our RSV vaccine is an important milestone for Moderna's efforts toward respiratory disease preparedness," said Stéphane Bancel, Chief Executive Officer of Moderna. "Our ...
Fat jabs warning as 82 deaths linked to weight loss drugs and expert warns, only take them if you REALLY need them
SOME 82 Brits have died after using weight-loss and diabetes jabs such as Ozempic and Mounjaro. The official figures from the ...
Warning after new death toll announced for people taking weight loss and diabetes jab
The Medicines and Healthcare products Regulatory Agency issued an alert as a crackdown on prescriptions was underway ...
The Financial Express4d
Weight loss jabs like Ozempic and Mounjaro linked to 82 deaths; Use with caution, experts warn
Around 82 people has died after using weight-loss and diabetes jabs such as Ozempic and Mounjaro. Up to the end of January, ...
Death toll linked with weight loss and diabetic drugs rises to 82 in the UK
The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...
Pharmabiz10d
UK MHRA grants marketing approval to Galderma’s nemolizumab to treat prurigo nodularis and atopic dermatitis
UK MHRA grants marketing approval to Galderma’s nemolizumab to treat prurigo nodularis and atopic dermatitis: United Kingdom Tuesday, February 18, 2025, 14:00 Hrs [IST] The Medi ...
JD Supra10d
UK’s MHRA Grants Marketing Authorization for Chikungunya Vaccine
Valneva SE (“Valneva”) announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) ...
Pharmabiz12d
UK MHRA approves Sobi’s efanesoctocog alfa to prevent and treat bleeding in children and adults with severe or moderate haemophilia A
UK MHRA approves Sobi’s efanesoctocog alfa to prevent and treat bleeding in children and adults with severe or moderate haemophilia A: United Kingdom Monday, February 17, 2025, ...